# US 2022/0031844 A1 · Semifluorinated alkane compositions comprising omega-3 fatty acid ethyl esters

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0031844 A1
- Document ID: US20220031844A1
- Status: Published application
- Kind: A1
- Application number: 17/297,580
- Filed: 2019-11-25
- Published: 2022-02-03
- Earliest claimed: 2018-11-27
- Applicants: Novaliq GmbH
- Inventors: Jörg Martin MAUDEN; Anja STICHER; Emanuele FRANZINI; Frank LÖSCHER; Michael COORS
- Web page: https://patentgrep.com/patent/US20220031844A1

## CPC

- A61K 47/06: Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K 9/0048: {Eye, e.g. artificial tears}
- A61K 9/08: Solutions {(composition of solutions A61K47/00)}
- A61K 31/232: having three or more double bonds, e.g. etretinate
- A61P 27/04: Artificial tears; Irrigation solutions
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The invention provides compositions comprising omega-3 fatty acid ethyl esters, specifically compositions that are based on semifluorinated alkanes. The compositions of the present invention may be topical ophthalmic compositions useful in the treatment of ocular diseases or conditions. The invention further provides kits comprising such compositions.

## Claims

### Claim 1

A stable liquid ophthalmic pharmaceutical composition comprising:
a) at least one omega-3 fatty acid ethyl ester in a total amount of up to 5 wt % based on the total weight of the composition;
b) a liquid paraffin in a total amount of up to 1 wt % based on the total weight of the composition;
wherein the at least one omega-3 fatty acid ethyl ester and the liquid paraffin are dissolved in a liquid vehicle comprising a semifluorinated alkane selected from 1-perfluorohexyl-octane (F6H8) or 1-perfluorobutyl-pentane (F4H5).

### Claim 2 (depends on 1)

The composition according to claim 1, wherein the total amount of liquid paraffin in wt % does not exceed the total amount of omega-3 fatty acid ethyl ester in wt %.

### Claim 3 (depends on 1)

The composition according to claim 1, wherein the at least one omega 3 fatty acid ethyl ester is eicosapentaenoic acid ethyl ester, docosahexaenoic ethyl ester or a mixture thereof.

### Claim 4 (depends on 1)

The composition according to claim 1, wherein the liquid paraffin is light liquid paraffin.

### Claim 5 (depends on 1)

The composition according to claim 1, wherein the composition substantially consists of at least one omega-3 fatty acid ethyl ester and a liquid paraffin dissolved in a semifluorinated alkane and optionally an antioxidant.

### Claim 6 (depends on 1)

The composition according to claim 1, comprising or consisting of up to 0.2 wt % of an omega-3 fatty acid ethyl ester selected from docosahexaenoic acid ethyl ester, eicosapentaenoic acid ethyl ester or mixtures thereof, 0.2 wt % light liquid paraffin, dissolved in a liquid vehicle comprising a semifluorinated alkane selected from F4H5, F6H8 and mixtures thereof and optionally up to 0.1 wt % of antioxidant.

### Claim 7 (depends on 1)

The composition according to claim 1, comprising up to 0.2 wt % docosahexaenoic acid ethyl ester, 0.2 wt % light liquid paraffin, at least 99 wt % of a semifluorinated alkane selected from F4H5, F6H8 and mixtures thereof, and optionally up to 0.1 wt % of antioxidant.

### Claim 8 (depends on 1)

The composition according to claim 1, essentially consisting of 0.2 wt % docosahexaenoic acid ethyl ester, 0.2 wt % light liquid paraffin, dissolved in a semifluorinated alkane selected from F4H5, F6H8 and mixtures thereof and optionally up to 0.1 wt % of antioxidant.

### Claim 9 (depends on 1)

The composition according to claim 1, essentially consisting of 0.2 wt % docosahexaenoic acid ethyl ester, 0.2 wt % light liquid paraffin, 0.0133 wt % butylhydroxyanisol, and 0.0067 wt % butylhydroxytoluene dissolved in F6H8.

### Claim 10 (depends on 1)

The composition according to claim 1, wherein the composition retains more than 75 wt % for 3 months of omega-3 ethyl ester upon storage at 40° C. at a relative humidity of 75%.

### Claim 11 (depends on 1)

The composition according to claim 1, wherein the oxygen content of the composition is below 0.90 μg/ml.

### Claim 12 (depends on 1)

A method for the treatment of a condition of the eye comprising administering to a patient in need thereof a composition according to claim 1.

### Claim 13 (depends on 12)

The method according to claim 12, wherein the composition is topically administered to the eye.

### Claim 14 (depends on 12)

The method according to claim 12, wherein the condition of the eye is selected from dry eye disease (keratoconjunctivitis sicca), evaporative dry eye disease, dry eye disease associated with Meibomian Gland Dysfunction, and Meibomian Gland Dysfunction or a symptom or condition associated therewith.

### Claim 15 (depends on 1)

A kit comprising a container comprising the ophthalmic composition according to claim 1, a dispensing means, and optionally instructions for use.

### Claim 16 (depends on 1)

A method for stabilizing a composition comprising one or more omega-3 fatty acid ethyl esters as defined in claim 1, comprising a step of mixing the one or more omega-3 fatty acid ethyl esters, a liquid paraffin and optionally one or more antioxidants, with a semifluorinated alkane to form a stable clear and colorless solution.

### Claim 17 (depends on 13)

The method according to claim 13, wherein the composition is topically administered to an eye surface, to the lacrimal sac, to the upper or lower eyelid or to an ophthalmic tissue
